By |

Equities News

Company chart and information is provided by TradingView based on 15-minute-delayed data.


Profile

ImmunityBio Inc is a late-clinical-stage immunotherapy company developing next-generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate (natural killer cell and macrophage) and adaptive (T cell) immune systems to create long-term immunological memory.

Contact Information

Website: www.immunitybio.com
Email: investors@nantkwest.com
Main Phone: +1 858 633-0300
Address: 3530 John Hopkins Court
State: CA
City / Town: San Diego
Country: US
Postal Code: 92121

Issuer Information

Exchange: NGS
CEO: Richard Adcock
Employees: 171
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)(541714)

Equities News

(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume N/A 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange N/A